PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23760395-0	2013	Mefloquine exerts anticancer activity in prostate cancer cells via ROS-mediated modulation of Akt, ERK, JNK and AMPK signaling.	Mefloquine	0-10	mitogen-activated protein kinase 8	Homo sapiens	104-107	
23760395-11	2013	Moreover, we observed that MQ-mediated ROS simultaneously downregulated Akt phosphorylation and activated extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and adenosine monophosphate-activated protein kinase (AMPK) signaling in PC3 cells.	Mefloquine	27-29	mitogen-activated protein kinase 8	Homo sapiens	151-174	
23760395-11	2013	Moreover, we observed that MQ-mediated ROS simultaneously downregulated Akt phosphorylation and activated extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and adenosine monophosphate-activated protein kinase (AMPK) signaling in PC3 cells.	Mefloquine	27-29	mitogen-activated protein kinase 8	Homo sapiens	176-179